Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription 27.07.2026 2 J Neural Transm (Vienna) 5 Mov Disord 2 Neurobiol Dis 1 Neurol Clin Pract 1 Neuroscience 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

J Neural Transm (Vienna)

1. POBUDEJSKI P, Tos M, Nyczka K, Duda K, et al
   Large language models as a screening tool for the qualification of patients with Parkinson's disease for device-aided therapies.
   J Neural Transm (Vienna). 2026 Jul 23. doi: 10.1007/s00702-026-03243.
   PubMed         Abstract available
   
   
2. SUKMUENG N, Phokaewvarangkul O, Bhidayasiri R
   Plant-derived therapies in Parkinson's disease: a systematic review of clinical evidence.
   J Neural Transm (Vienna). 2026 Jul 23. doi: 10.1007/s00702-026-03239.
   PubMed         Abstract available
   
   

   
   Mov Disord

3. COUSSEDIERE C, Pereira B, Devos D, Lehericy S, et al
   One-Year Substantia Nigra R2* Changes across Parkinson's Disease Stages.
   Mov Disord. 2026 Apr 27. doi: 10.1002/mds.70331.
   PubMed         Abstract available
   
   
4. KOUCHACHE T, Chan T, Sun S, Liu L, et al
   Association Between Plasma Phosphorylated Tau-217 and Cognition in Parkinson's Disease.
   Mov Disord. 2026 Jul 19. doi: 10.1002/mds.70400.
   PubMed         Abstract available
   
   
5. SEKIYA H, Jensen NM, Dickson DW, Jensen PH, et al
   Seeing Invisible Oligomers: Rethinking alpha-Synuclein Pathology Through Proximity Ligation Assay.
   Mov Disord. 2026;41:1680-1689.
   PubMed         Abstract available
   
   
6. ORSO B, Roura I, Mattioli P, Fama F, et al
   [(18)F]Fluorodeoxyglucose positron emission tomography ([(18)F]FDG PET) Characterizes Neurodegeneration Levels Across the alpha-Synucleinopathy Continuum.
   Mov Disord. 2026;41:1786-1797.
   PubMed         Abstract available
   
   
7. BAUN AM, Iranzo A, Terkelsen MH, Hinz R, et al
   Differential Progression of Neuroinflammation in Patients with Isolated Rapid-Eye-Movement Sleep Behavior Disorder.
   Mov Disord. 2026;41:1893-1898.
   PubMed         Abstract available
   
   

   
   Neurobiol Dis

8. DONG L, Yan Y, Wang S, Wang Z, et al
   Adaptations of the limbic system and corpus callosum white matter in early-stage PD with RBD.
   Neurobiol Dis. 2026;227:107510.
   PubMed         Abstract available
   
   
9. BARTALIS AE, Genschmar J, Fitzgerald JC, Hermann A, et al
   Miro1 mutations disrupt cellular calcium homeostasis via dysregulation of mitochondria-ER-contact-sites, rendering iPSC-derived neurons more susceptible to lipid peroxidation.
   Neurobiol Dis. 2026;227:107492.
   PubMed         Abstract available
   
   

   
   Neurol Clin Pract

10. SESHADRI S, Ferrell B, Aamodt WW, Contento A, et al
    Priorities to Improve Caregiving Experiences in Parkinson Disease: A Qualitative Study of Multiple Stakeholders.
    Neurol Clin Pract. 2026;16:e200649.
    PubMed         Abstract available
    
    

    
    Neuroscience

11. LIN H, Dai W, Mao H, Kuang Y, et al
    Neural compensation preserves white matter integrity in early Parkinson's disease but not atypical Parkinsonism: a diffusion tensor imaging study.
    Neuroscience. 2026 Jul 20:S0306-4522(26)00477.
    PubMed         Abstract available
    
    

    
    PLoS One

12. HAYNES JM
    G-protein coupled receptor, signal and signal-transduction related transcript mapping in nigral volume and pigmented neurons reveals a potential deficit of nigral feedback signals associated with Parkinson's disease.
    PLoS One. 2026;21:e0352503.
    PubMed         Abstract available
    
    
13. WANG B, Huang Z, Wang R, Zhu C, et al
    Research advances in key genes and regulatory mechanisms of posttranslational modifications in Parkinson's disease.
    PLoS One. 2026;21:e0354097.
    PubMed         Abstract available
    
    
14. LYU Y, Chen J, Zeng S
    Optimal exercise modalities and dosages for improving depression in middle-aged and older adults with Parkinson's disease: A Bayesian Dose-response network meta-analysis.
    PLoS One. 2026;21:e0354206.
    PubMed         Abstract available
    
    
15. ABUR D, Cushman M, Dunsmuir CJ, Stepp CE, et al
    Comparing token-based and trajectory-based vowel space metrics for assessing speech in Parkinson's disease.
    PLoS One. 2026;21:e0353680.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum